Mereo BioPharma Group plc (MREO) Reports In-Line Q3 EPS

Mereo BioPharma Group plc (NASDAQ: MREO) reported Q3 EPS of ($0.02), in-line with the analyst estimate of ($0.02).

For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Coherent starts sampling 300mm silicon carbide substrates for AI chips
• argenx SE (ARGX) PT Raised to $1,095 at Truist Securities